2021 - NCI-CONNECTions
-
New Research Shows How Patients with Brain and Spine Tumors are ImpactedFive nurses share data from the Natural History Study, which aims to better understand brain and spine tumors and uncover areas for further research.
-
Neuro-Oncology Branch Receives Awards at the 2021 SNO Annual MeetingTwo physicians share findings from the NCI-CONNECT Immunotherapy and Natural History Studies in award-winning abstracts.
-
Near-Death Experiences Guided by FaithTom survived a car crash, two bouts of cancer, and an autoimmune disorder. He shares how faith got him through hard times and changed his outlook.
-
Neurosurgeon Values Teamwork for Optimal CareNeurosurgeon Dr. John Heiss shares how his ability to provide the best care for rare brain and spinal cord tumors depends heavily on teamwork, both inside and outside of the operating room.
-
First-in-Human Trial for People with Recurrent Rare CNS TumorsNCI-CONNECT launched a first-in-human phase I clinical trial for people with recurrent rare brain and spine tumors as a first step in the development of a novel drug for patients.
-
New Immunotherapy Study for GlioblastomaA clinical trial investigates immune checkpoint inhibitors with standard treatment in people with aggressive brain cancers to understand the immune system response and improve long-term outcomes.
-
Working Toward Better Radiation Responses Through Novel, Targeted DrugsRadiation oncologist Dr. Kevin Camphausen is helping people with brain and spine tumors by developing drugs that can enhance the radiation impact with the goal to improve patient outcomes.
-
An Immunotherapy Drug Trial Expands Across the Nation to Advance ResearchNCI-CONNECT launched an immunotherapy drug trial across its national network of collaborative institutions to reach more people with rare brain and spine tumors.
-
Symposium to Advance Neuro-Oncology Survivorship CareNeuro-oncology providers, researchers, advocates, patients, and care partners gathered virtually to learn and discuss the challenges experienced by persons living with brain and spine tumors and develop survivorship care guidelines.
-
Oral Drug Combination Shows Benefit for Adults with EpendymomaLearn how results from the first prospective clinical trial for adults with ependymoma led to a change in treatment guidelines.